The Journal of infectious diseases · 2026
BK Polyomavirus Genetic Diversity and Evolution in Kidney Transplant Recipients With Viral Nephropathy According to Whole Genome Sequencing.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gras Julien, Nere Marie Laure, Robert Julien, Louis Kevin, Peraldi Marie Noëlle, Feghoul Linda, Verine Jérôme, Amara Ali, Lefaucheur Carmen, Molina Jean Michel, Delaugerre Constance, Salmona Maud
Аннотация
BACKGROUND: Among kidney transplant recipients (KTRs) with BK polyomavirus (BKPyV)-associated nephropathy (BKPyVN), the dynamics of BKPyV replication are not well established. We aim to investigate BKPyV genetic diversity and evolution following kidney transplant.
METHODS: We retrospectively analyzed 32 KTRs with a biopsy-proven diagnosis of BKPyVN. Stored plasma and kidney biopsies were tested for BKPyV viral load, and BKPyV whole genome sequencing was performed on BKPyV-positive samples.
RESULTS: A total of 104 samples positive for BKPyV DNA detection were sequenced, among which 83 were included in the analysis. BKPyV-I was the most frequent genotype detected, followed by BKPyV-IVc2 and BKPyV-II. At BKPyVN diagnosis (median [IQR], 12 [8-17] months posttransplant), whole genome sequencing identified the same BKPyV subtype in the plasma and kidney biopsy for all patients but one. Alignment of BKPyV consensus sequences between the 2 compartments at the time of BKPyVN showed similarity >99% but identified single-nucleotide polymorphisms in 13 of 23 cases, including 25% APOBEC-associated mutations. Among the 16 KTRs with ≥2 consecutive BKPyV-positive samples available for analysis, consensus sequence showed a different BKPyV subtype in pre-BKPyVN kidney biopsies as compared with BKPyVN in 9 patients. Before BKPyVN diagnosis, minority variants on the VP1 sequence were identified in 10 of 11 kidney biopsy samples and 5 of 10 plasma samples.
CONCLUSIONS: Among KTRs with BKPyVN, we show that BKPyV viral populations change over time, with the coexistence of several viral populations in early samples as compared with BKPyVN, as a result of APOBEC-mediated editing and replication-driven diversification within the kidney allograft.
METHODS: We retrospectively analyzed 32 KTRs with a biopsy-proven diagnosis of BKPyVN. Stored plasma and kidney biopsies were tested for BKPyV viral load, and BKPyV whole genome sequencing was performed on BKPyV-positive samples.
RESULTS: A total of 104 samples positive for BKPyV DNA detection were sequenced, among which 83 were included in the analysis. BKPyV-I was the most frequent genotype detected, followed by BKPyV-IVc2 and BKPyV-II. At BKPyVN diagnosis (median [IQR], 12 [8-17] months posttransplant), whole genome sequencing identified the same BKPyV subtype in the plasma and kidney biopsy for all patients but one. Alignment of BKPyV consensus sequences between the 2 compartments at the time of BKPyVN showed similarity >99% but identified single-nucleotide polymorphisms in 13 of 23 cases, including 25% APOBEC-associated mutations. Among the 16 KTRs with ≥2 consecutive BKPyV-positive samples available for analysis, consensus sequence showed a different BKPyV subtype in pre-BKPyVN kidney biopsies as compared with BKPyVN in 9 patients. Before BKPyVN diagnosis, minority variants on the VP1 sequence were identified in 10 of 11 kidney biopsy samples and 5 of 10 plasma samples.
CONCLUSIONS: Among KTRs with BKPyVN, we show that BKPyV viral populations change over time, with the coexistence of several viral populations in early samples as compared with BKPyVN, as a result of APOBEC-mediated editing and replication-driven diversification within the kidney allograft.